
0.066 Delayed Data As of Feb 22 | ![]() Today’s Change | 0.03 Today|||52-Week Range 0.12 | +100.00% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Poniard Pharmaceuticals Inc have a median target of 80.00, with a high estimate of 80.00 and a low estimate of 80.00. The median estimate represents a +121,112.12% increase from the last price of 0.07.
The current consensus among 1 polled investment analysts is to Hold stock in Poniard Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.